FRI-399 Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients.
Journal of Hepatology.
High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study.
Orphanet Journal of Rare Diseases.
Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
Scandinavian Journal of Gastroenterology.
Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
Journal of Gastroenterology and Hepatology.
The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.
The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation.
Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD.
Current Hepatology Reports.
The damage‐associated molecular pattern HMGB1 is elevated in human alcoholic hepatitis, but does not seem to be a primary driver of inflammation.
Circulating mannan‐binding lectin, M‐, L‐, H‐ficolin and collectin‐liver‐1 levels in patients with acute liver failure.
Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.
AJP Gastrointestinal and Liver Physiology.
Multiple logistic regression analyses of the relationships between Clinically significant portal hypertension & sMR, CRP, GEC, and MELD-score..
Study entry characteristics of patients with alcoholic hepatitis and patients with stable alcoholic liver cirrhosis and healthy persons (Data are median (interquartile range))..